VANCOUVER, B.C, January 16, 2023 /CNW/ – PanGenomic Health Inc . (“PanGenomic Health” or the “Company”) (CSE: NARA) (FSE: LL30) is pleased to announce that its newly acquired subsidiary, Mindleap Health Inc. (“Mindleap”) this quarter will expand its current programs and practitioner specialties to enable a comprehensive app and telehealth platform for holistic mental wellness.
According to the National Institute of Mental Health, an estimated 26% of adults 18 and older suffer from a diagnosable mental disorder in a given year.1 Mindleap aims to improve the delivery of mental wellness, from mood disorders to daily resilience and capacity building, by providing a more cost-effective all-in-one app and telehealth platform that improves accessibility and saves time for both users and clinicians. New content will be added to Mindleap’s library to educate and guide users through state-of-the-art programs and new tools such as Internal Family Systems (IFS), Non-Sleep Deep Rest (NSDR) and Vagal Nerve Stimulation (VNS).
Mindleap’s app and telehealth platform empowers users to take charge of their own mental health journey by accessing a wider range of programs that include new approaches to mental health management and empowers the user to speak with a practitioner through Mindleap’s telehealth features.
The healthcare market is expected to grow at a CAGR of 26.3% and reach USD 711 billion dollars by 2029, according to Databridge Market Research.2
Maryam MarissenCEO of Mindleap’s parent company, PanGenomic Health, said: “Mental health management is a lifelong endeavor and we want to bring more cutting-edge tools, programs and practitioners to our Mindleap platform. Not only do we want to help people with their immediate mental health concerns, we also want to help people build daily resilience in the modern world. for the world.
|
________________________________ |
|
1 https://www.hopkinsmedicine.org/health/wellness-and-prevention/mental-health-disorder-statistics |
|
2 https://www.databridgemarketresearch.com/reports/global-telemental-health-market |
About PanGenomic Health
PanGenomic Health is a precision healthcare company that has developed a self-care digital platform to provide personalized evidence-based information about natural therapies. The company’s initial focus is on supporting mental health. Registered as a British Columbia PanGenomic Health’s mission is to advance and improve the health and well-being of individuals and society by providing a technology platform that identifies plant-based solutions tailored to each individual’s health profile.
This press release contains certain statements that may be considered forward-looking statements, including statements regarding PanGenomic Health’s services and the payment to PanGenomic Health. The use of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “would”, “would”, “project”, “should”, “believe” and the like are intended to identify forward-looking statements. Although PanGenomic Health believes that the expectations and assumptions on which forward-looking statements are based are reasonable, undue reliance should not be placed on forward-looking statements because PanGenomic Health can give no assurance that they will prove to be correct. . In particular, there can be no assurances regarding PanGenomic Health’s future financial performance. Future market growth and overall market size for natural health products and over-the-counter drugs may not be indicative of PanGenomic Health’s future performance, and there can be no assurance that PanGenomic Health will be able to capture any particular portion of these markets. . Because forward-looking statements address future events and conditions, they inherently involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results may differ materially from those currently anticipated due to a number of factors and risks, including a number of risk factors discussed in PanGenomic Health’s disclosure documents, which can be found under PanGenomic Health’s profile www.sedar.com.
The Canadian Securities Exchange has not endorsed or disapproved of the information contained herein and assumes no responsibility for the adequacy or accuracy of this press release.
SOURCE PanGenomic Health Inc.
